419985007: Deferasirox (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Chelating agent\Deferasirox (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antidote (substance)\Deferasirox (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Substance with triazole structure (substance)\Deferasirox (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Substance with triazole structure (substance)\Deferasirox (substance)
\Organic compound\Organic nitrogen compound\Azole\Substance with triazole structure (substance)\Deferasirox (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Deferasirox (substance)	Is a	Chelating agent	true	Inferred relationship	Some
Deferasirox (substance)	Is a	Triazole derivative	false	Inferred relationship	Some
Deferasirox (substance)	Is a	Heavy metal antagonist (substance)	false	Inferred relationship	Some
Deferasirox (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that forms a complex with metal ions or other substrates	true	Inferred relationship	Some
Deferasirox (substance)	Is a	Antidote (substance)	true	Inferred relationship	Some
Deferasirox (substance)	Is a	Substance with triazole structure (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing deferasirox (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Deferasirox (substance)	Inferred relationship	Some
Product containing precisely deferasirox 250 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Deferasirox (substance)	Inferred relationship	Some
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Deferasirox (substance)	Inferred relationship	Some
Product containing deferasirox in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Deferasirox (substance)	Inferred relationship	Some	1
Deferasirox only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Deferasirox (substance)	Inferred relationship	Some	1
Deferasirox only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 250 milligram/1 each tablet for conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 250 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Deferasirox (substance)	Inferred relationship	Some	1
Deferasirox therapy	Direct substance	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 90 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 90 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Deferasirox (substance)	Inferred relationship	Some	1
Deferasirox 180 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Deferasirox (substance)	Inferred relationship	Some	1
Deferasirox 180 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Deferasirox (substance)	Inferred relationship	Some	1
Deferasirox 360 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Deferasirox (substance)	Inferred relationship	Some	1
Deferasirox 360 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 400 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 400 milligram/1 each tablet for conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 100 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Deferasirox (substance)	Inferred relationship	Some	1
Product containing precisely deferasirox 100 milligram/1 each tablet for conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Deferasirox (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2575397011	Deferasirox (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2578840016	Deferasirox	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
58311000195111	deferasirox	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
804201000172113	déférasirox	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
73401000195110	Deferasirox	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module